§ 283e. Plan for use of animals in research
(a)
Preparation
The Director of NIH, after consultation with the committee established under subsection (e) of this section, shall prepare a plan—
(1)
for the National Institutes of Health to conduct or support research into—
(B)
methods of such research and experimentation that reduce the number of animals used in such research;
(b)
Submission to Congressional committees
Not later than October 1, 1993, the Director of NIH shall submit to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, the plan required in subsection (a) of this section and shall begin implementation of the plan.
(c)
Periodic review and revision
The Director of NIH shall periodically review, and as appropriate, make revisions in the plan required under subsection (a) of this section. A description of any revision made in the plan shall be included in the first biennial report under section
283 of this title that is submitted after the revision is made.
(d)
Dissemination of information
The Director of NIH shall take such actions as may be appropriate to convey to scientists and others who use animals in biomedical or behavioral research or experimentation information respecting the methods found to be valid and reliable under subsection (a)(2) of this section.
(e)
Interagency Coordinating Committee on the Use of Animals in Research
(1)
The Director of NIH shall establish within the National Institutes of Health a committee to be known as the Interagency Coordinating Committee on the Use of Animals in Research (in this subsection referred to as the “Committee”).
(2)
The Committee shall provide advice to the Director of NIH on the preparation of the plan required in subsection (a) of this section.
(3)
The Committee shall be composed of—
(A)
the Directors of each of the national research institutes and the Director of the Center for Research Resources (or the designees of such Directors); and
(B)
representatives of the Environmental Protection Agency, the Food and Drug Administration, the Consumer Product Safety Commission, the National Science Foundation, and such additional agencies as the Director of NIH determines to be appropriate, which representatives shall include not less than one veterinarian with expertise in laboratory-animal medicine.